ProShares UltraShort Nasdaq Biotechnology (BIS) Institutional Ownership $20.23 +0.13 (+0.65%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartDividendHoldingsOptions ChainOwnershipShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$670.74KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$183.90K Get BIS Insider Trade Alerts Want to know when executives and insiders are buying or selling ProShares UltraShort Nasdaq Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BIS Institutional Buying and Selling by Quarter Remove Ads ProShares UltraShort Nasdaq Biotechnology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2025Jane Street Group LLC38,696$704K0.0%+267.8%19.348% 2/14/2025Tower Research Capital LLC TRC 5,321$97K0.0%-65.5%2.661% 11/15/2024Jane Street Group LLC10,520$158K0.0%N/A4.782% 4/13/2024 IMC Chicago LLC25,210$443K0.0%+68.1%11.459% 2/13/2024Tower Research Capital LLC TRC4,721$85K0.0%-53.4%1.004% 2/9/2024 IMC Chicago LLC15,001$271K0.0%N/A3.192% 11/10/2022Tower Research Capital LLC TRC8,123$205K0.0%-9.2%2.708% 11/8/2022 IMC Chicago LLC23,335$590K0.0%+11.1%7.778% 8/5/2022 IMC Chicago LLC21,003$566K0.0%+12.5%5.251% 8/5/2022OLD Mission Capital LLC15,311$413K0.0%-52.5%3.828% 4/19/2022 IMC Chicago LLC18,668$450K0.0%N/A5.395% 2/10/2022OLD Mission Capital LLC13,257$266K0.0%N/A3.348% 11/5/2021 IMC Chicago LLC27,459$495K0.0%+93.3%6.934% 8/13/2021OLD Mission Capital LLC30,214$556K0.0%-33.8%6.774% 8/11/2021Susquehanna International Group LLP34,616$637K0.0%-26.5%7.761% 8/6/2021 IMC Chicago LLC14,203$261K0.0%+5.4%3.185% 5/18/2021Citadel Advisors LLC11,342$256K0.0%N/A2.543% (Data available from 1/1/2016 forward)Remove Ads BIS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BIS shares? During the previous two years, the following institutional investors and hedge funds held shares of ProShares UltraShort Nasdaq Biotechnology shares: Jane Street Group LLC ($704K), and IMC Chicago LLC ($443K), Tower Research Capital LLC TRC ($97K).Learn more on BIS's institutional investors. Which institutional investors have been buying ProShares UltraShort Nasdaq Biotechnology stock? The following institutional investors have purchased ProShares UltraShort Nasdaq Biotechnology stock in the last 24 months: Jane Street Group LLC ($38.70K), and IMC Chicago LLC ($25.21K). How much institutional buying is happening at ProShares UltraShort Nasdaq Biotechnology? Institutional investors have bought a total of 63,906 shares in the last 24 months. This purchase volume represents approximately $1.12M in transactions. Which ProShares UltraShort Nasdaq Biotechnology major shareholders have been selling company stock? The following institutional investors have sold ProShares UltraShort Nasdaq Biotechnology stock in the last 24 months: Tower Research Capital LLC TRC ($15.51K). How much institutional selling is happening at ProShares UltraShort Nasdaq Biotechnology? Institutional investors have sold a total of 15,514 shares in the last 24 months. This volume of shares sold represents approximately $281.55K in transactions. Related Companies JPMorgan Healthcare Leaders ETF Institutional Ownership First Trust Nasdaq Pharmaceuticals ETF Institutional Ownership Invesco Nasdaq Biotechnology ETF Institutional Ownership ProShares Ultra Nasdaq Biotechnology Institutional Ownership Invesco Dorsey Wright Healthcare Momentum ETF Institutional Ownership Invesco S&P SmallCap Health Care ETF Institutional Ownership VanEck Biotech ETF Institutional Ownership VanEck Pharmaceutical ETF Institutional Ownership iShares Biotechnology ETF Institutional Ownership This page (NASDAQ:BIS) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares UltraShort Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares UltraShort Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BIS Stock Free BIS Stock Alerts